See analyst estimates and all valuation multiples for Medical Supplies
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $181B | 4.2x | 16.7x | |
| $151B | 6.3x | 19.8x | |
| $68.4B | 3.2x | 11.1x | |
| $39.4B | 1.6x | 9.7x | |
| $37.9B | 6.3x | 17.9x | |
| $35.9B | 6.8x | 18.4x | |
| $27.4B | 3.8x | 16.2x | |
| $27.4B | 1.2x | 6.9x | |
| $25.9B | 4.7x | 16.1x | |
| $20.6B | 6.6x | 21.3x | |
| $15.2B | 2.5x | 9.9x | |
| $15.0B | 5.1x | 20.8x | |
| $12.7B | 1.9x | 10.6x | |
| $11.4B | 3.1x | 14.4x | |
| $8.2B | 2.7x | 11.6x | |
| $6.6B | 5.3x | 21.8x | |
| $5.6B | 5.0x | 9.9x | |
| $5.3B | 1.4x | 8.0x | |
| $4.8B | 4.3x | 16.0x | |
| $4.7B | 1.9x | 9.0x | |
| $4.2B | 3.1x | 10.0x | |
| $3.7B | n/a | n/a | |
| $3.5B | 1.7x | 10.4x | |
| $3.1B | 1.5x | 7.0x | |
| $2.6B | 12.8x | 47.1x | |
| $2.0B | 1.8x | 5.1x | |
| $1.6B | n/a | n/a | |
| $1.5B | 2.0x | 7.3x | |
| $1.2B | 6.0x | n/a | |
| $1.1B | n/a | n/a | |
| $1.1B | 0.8x | 7.5x | |
| $1000M | 11.3x | 55.4x | |
| $891M | n/a | n/a | |
| $838M | n/a | n/a | |
| $665M | 1.1x | 5.1x | |
| $546M | 3.8x | 8.5x | |
| $424M | 3.6x | 39.7x | |
| $423M | 5.4x | 29.1x | |
| $286M | n/a | n/a | |
| $285M | n/a | n/a | |
| $265M | n/a | n/a | |
| $254M | 1.2x | 35.7x | |
| $229M | 7.8x | 42.9x | |
| $210M | 0.8x | 6.8x | |
| $206M | n/a | n/a | |
| $199M | n/a | n/a | |
| $191M | 3.2x | 16.5x | |
| $157M | 0.6x | 2.8x | |
| $130M | n/a | n/a | |
| $82.5M | 1.3x | 7.3x | |
| $46.2M | 0.9x | 13.2x | |
| $46.1M | n/a | n/a | |
| $37.1M | 5.8x | n/a | |
| $27.9M | 0.3x | 14.9x | |
| $23.5M | n/a | n/a | |
| $17.1M | 8.4x | n/a | |
| $15.2M | n/a | n/a | |
| $11.5M | n/a | n/a | |
| $11.2M | n/a | n/a | |
| $9.0M | n/a | n/a | |
| $3.9M | n/a | n/a | |
| $1.6M | n/a | n/a | |
| $1.4M | n/a | n/a | |
| $1.1M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Medical Supplies